Tibalosin

Tibalosin
Nazivi
	Preferisani IUPAC naziv (1S,2R)-1-(2,3-dihidro-1-benzotiofen-5-il)-2-(4-fenilbutilamino)propan-1-ol
	Drugi nazivi CHEMBL4762639 • 1,2,3-dihidro-5-benzo(b)tienil-2-(4-fenilbutilamino)-1-propanol • CP 804-S • CP-804S • tibalosine • 2H3X1M329K • Tibalosina • 63996-84-9 • Tibalosinum • CP-804S • UNII-2H3X1M329K • DTXSID801031652 • Q27254733
Identifikacija
CAS broj	63996-84-9 ;
3D model (Jmol)	interaktivna slika;
ChemSpider	143105;
PubChem C ID	76971717;
UNII	2H3X1M329K ;
	SMILES CC(C(C1=CC2=C(C=C1)SCC2)O)NCCCCC3=CC=CC=C3; ; ; ; ; ;
Svojstva
Hemijska formula	C21H27NOS
Molarna masa	341,51 g·mol−1
	Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa).
	Reference infokutije

Tibalosin je antagonist alfa adrenergičkog receptora.^[3]

Reference уреди

^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003. уреди
^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
^ „Tibalosin: an effective antihypertensive agent both alone and in combination with atenolol”. InPharma. 540: 6. 2013. doi:10.1007/BF03299238.